CLOV Valuation

Clover Health Investments Corp

Add to Watchlist

Advanced Chart

3.075

-0.335(-9.824%)1D

Overview
Forecast
Valuation
Earnings

CLOV Relative Valuation

CLOV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLOV is overvalued; if below, it's undervalued.

Historical Valuation

Clover Health Investments Corp (CLOV) is now in the Fair zone, suggesting that its current forward PS ratio of 0.88 is considered Fairly compared with the five-year average of -9.45. The fair price of Clover Health Investments Corp (CLOV) is between 2.79 to 4.08 according to relative valuation methord.

Relative Value

Fair Zone

2.79-4.08

Current Price：3.08

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

5.14

P/B

Median3y

2.79

Median5y

3.04

-0.50

FCF Yield

Median3y

-21.94

Median5y

-19.84

Competitors Valuation Multiple

The average P/S ratio for CLOV's competitors is 0.68, providing a benchmark for relative valuation. Clover Health Investments Corp Corp (CLOV) exhibits a P/S ratio of 0.88, which is 28.70% above the industry average. Given its robust revenue growth of 33.27%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

CLOV.O

Clover Health Investments Corp

0.88

Average P/S: 0.68

33.27%